{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:47:53Z","timestamp":1772524073456,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2200,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.bbmt.2008.12.493","type":"journal-article","created":{"date-parts":[[2009,2,13]],"date-time":"2009-02-13T13:35:44Z","timestamp":1234532144000},"page":"505-511","source":"Crossref","is-referenced-by-count":27,"title":["First-Line Therapy for Chronic Graft-versus-Host Disease that Includes Low-Dose Methotrexate Is Associated with a High Response Rate"],"prefix":"10.1016","volume":"15","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan-ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai-hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2008.12.493_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bmt.1705445","article-title":"Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological disease","volume":"38","author":"Huang","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.12.493_bib2","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","article-title":"Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation","volume":"107","author":"Lu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.12.493_bib3","first-page":"624","article-title":"A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors","volume":"45","author":"Chen","year":"2006","journal-title":"Chin J Intern Med"},{"key":"10.1016\/j.bbmt.2008.12.493_bib4","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood.V77.8.1821.1821","article-title":"A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment","volume":"77","author":"Martin","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.12.493_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/bbmt.2002.v8.pm11939605","article-title":"Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment","volume":"8","author":"Arai","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.12.493_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2165\/00003088-200342020-00003","article-title":"Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic disease","volume":"42","author":"Grim","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bbmt.2008.12.493_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-110-5-353","article-title":"Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease","volume":"110","author":"Kozarek","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2008.12.493_bib8","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0022-3476(98)70313-0","article-title":"Methotrexate in patients with Crohn's disease after 6-mercaptopurine","volume":"132","author":"Mack","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2008.12.493_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s002960050058","article-title":"Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanism","volume":"18","author":"Boehm","year":"1998","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.bbmt.2008.12.493_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0049-0172(98)80049-8","article-title":"Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity","volume":"27","author":"van Ede","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.bbmt.2008.12.493_bib11","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJM199310213291703","article-title":"Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease","volume":"329","author":"Chao","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.12.493_bib12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJM198603203141201","article-title":"Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia","volume":"314","author":"Storb","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.12.493_bib13","first-page":"2062","article-title":"Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors","volume":"96","author":"Nash","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.12.493_bib14","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1182\/blood.V88.11.4383.4383","article-title":"Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation","volume":"88","author":"Przepiorka","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.12.493_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/sj.bmt.1705022","article-title":"Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease","volume":"36","author":"Giaccone","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.12.493_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.bmt.1705922","article-title":"Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children","volume":"41","author":"Inagaki","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.12.493_bib17","first-page":"1438","article-title":"Low-dose methotrexate as salvage therapy for refractory graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation","volume":"91","author":"de Lavallade","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2008.12.493_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.bmt.1705034","article-title":"Low-dose methotrexate for the treatment of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"36","author":"Huang","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.12.493_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host disease syndrome in man. A long-term clinico-pathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2008.12.493_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clim.2004.09.001","article-title":"The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules","volume":"114","author":"Johnston","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.bbmt.2008.12.493_bib21","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM199204163261604","article-title":"Thalidomide for the treatment of chronic graft-versus-host disease","volume":"326","author":"Vogelsang","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2008.12.493_bib22","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1182\/blood.V86.9.3604.bloodjournal8693604","article-title":"Thalidomide as salvage therapy for chronic graft-versus-host disease","volume":"86","author":"Parker","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.12.493_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.bmt.1702741","article-title":"A three or more drug combination as effective therapy for moderate or severe chronic graft-versus-host disease","volume":"27","author":"Gaziev","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.12.493_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/bbmt.2003.50003","article-title":"Chronic graft-versus-host disease: a prospective cohort study","volume":"9","author":"Arora","year":"2003","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108011038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108011038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T19:13:11Z","timestamp":1589569991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879108011038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1083879108011038"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.12.493","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}